Efficacy of a Probiotic and Herbal Supplement in Models of Lung Inflammation

Nancy M Wenger1, Luhua Qiao2, Teodora Nicola2

  • 1ResBiotic Nutrition Inc., Birmingham, AL 35203, USA.

Microorganisms
|November 11, 2022
PubMed
Abstract

Insights

A probiotic and herbal supplement (resB) reduced lung inflammation and injury in preclinical models. This blend decreased neutrophil recruitment and inflammatory markers, suggesting potential for treating lung diseases linked to gut microbiome imbalances.

Area of Science:

  • Microbiology
  • Immunology
  • Pharmacology

Background:

  • Gut microbiome dysbiosis is linked to lung disease via the gut-lung axis.
  • Elevated proteobacteria promote matrix metalloproteinase-9 (MMP-9) activity, leading to tissue damage and inflammation.
  • This contributes to neutrophil recruitment, lung injury, and chronic lung disease progression.

Purpose of the Study:

  • To investigate if a probiotic and herbal supplement (resB) can reduce neutrophilic inflammation.
  • To determine if resB can improve lung structure and function in inflammation models.

Main Methods:

  • In vitro: Epithelial cells exposed to proteobacteria were treated with resB (probiotic Lactobacillus strains, turmeric, holy basil, vasaka).
  • In vivo: Mice exposed to lipopolysaccharide (LPS) were treated with resB via gavage.

Main Results:

  • In vitro, resB components inhibited MMP-9 pathway activity.
  • In vivo, resB treatment decreased neutrophil recruitment and inflammatory biomarkers in lung lavage fluid, serum, and tissue.
  • These effects were observed in mice pre- and post-LPS exposure.

Conclusions:

  • The study elucidates the mechanisms by which resB modulates lung inflammation.
  • resB demonstrated efficacy in preclinical models of lung injury and inflammation.
  • This probiotic and herbal blend shows potential for therapeutic intervention in lung diseases.